Nash Huw M. has filed 14 insider transactions across 1 company since March 2024.
Most recent transaction: a sale of 33 shares of Stoke Therapeutics, Inc. ($STOK) on July 02, 2024.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 2, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | Chief Business Officer | S | Common Stock | 33 | $13.90 | 0.0000 | 43,994,862 | 100.00% | 0.00% |
| July 2, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | Chief Business Officer | S | Common Stock | 2467 | $13.10 | 33.0000 | 43,994,862 | 98.68% | 0.01% |
| March 27, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | A | Employee Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 43,994,862 | 9999.99% | 0.14% |
| March 27, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | A | Restricted Stock Units | 40000 | $0.00 | 40,000.0000 | 43,994,862 | 9999.99% | 0.09% |
| May 20, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | M | Stock Option (Right to Buy) | 50000 | $0.00 | 46,000.0000 | 43,994,862 | 52.08% | 0.11% |
| May 20, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | M | Common Stock | 50000 | $0.40 | 50,000.0000 | 43,994,862 | 9999.99% | 0.11% |
| May 20, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | S | Common Stock | 50000 | $15.39 | 0.0000 | 43,994,862 | 100.00% | 0.11% |
| April 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | M | Common Stock | 50000 | $0.40 | 61,329.0000 | 43,994,862 | 441.35% | 0.11% |
| April 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | S | Common Stock | 60929 | $13.22 | 400.0000 | 43,994,862 | 99.35% | 0.14% |
| April 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | S | Common Stock | 400 | $13.61 | 0.0000 | 43,994,862 | 100.00% | 0.00% |
| April 1, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | M | Stock Option (Right to Buy) | 50000 | $0.00 | 96,000.0000 | 43,994,862 | 34.25% | 0.11% |
| March 15, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | M | Common Stock | 13100 | $0.00 | 15,445.0000 | 43,994,862 | 558.64% | 0.03% |
| March 19, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | S | Common Stock | 4116 | $6.10 | 11,329.0000 | 43,994,862 | 26.65% | 0.01% |
| March 15, 2024 | Stoke Therapeutics, Inc. | $STOK | Nash Huw M. | COO & CBO | M | Restricted Stock Units | 13100 | $0.00 | 39,300.0000 | 43,994,862 | 25.00% | 0.03% |